Hydrogel-based Drug Delivery System Market Size, Share & Trends Analysis Report By Polymer Origin (Natural, Synthetic, Hybrid), By Route (Subcutaneous, Ocular, Oral Cavity)- Global Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2021-2027

Chapter 1.    Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.    Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.    Executive Summary

3.1.  Market Snapshot

Chapter 4.    Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.     Raw Material Procurement Analysis

4.3.2.     Sales and Distribution Channel Analysis

4.3.3.     Downstream Buyer Analysis

Chapter 5.    Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.     Market Drivers

5.1.2.     Market Restraints

5.1.3.     Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.     Bargaining power of suppliers

5.2.2.     Bargaining power of buyers

5.2.3.     Threat of substitute

5.2.4.     Threat of new entrants

5.2.5.     Degree of competition

Chapter 6.    Competitive Landscape

6.1.1.     Company Market Share/Positioning Analysis

6.1.2.     Key Strategies Adopted by Players

6.1.3.     Vendor Landscape

6.1.3.1.          List of Suppliers

6.1.3.2.          List of Buyers

Chapter 7.    Global Hydrogel-Based Drug Delivery System Market, By Polymer Origin

7.1.  Hydrogel-Based Drug Delivery System Market, By Polymer Origin, 2021-2027

7.1.1.     Natural

7.1.1.1.          Market Revenue and Forecast (2016-2027)

7.1.2.     Synthetic

7.1.2.1.          Market Revenue and Forecast (2016-2027)

7.1.3.     Hybrid

7.1.3.1.          Market Revenue and Forecast (2016-2027)

Chapter 8.    Global Hydrogel-Based Drug Delivery System Market, By Delivery Route

8.1.  Hydrogel-Based Drug Delivery System Market, By Delivery Route, 2021-2027

8.1.1.     Subcutaneous

8.1.1.1.          Market Revenue and Forecast (2016-2027)

8.1.2.     Ocular

8.1.2.1.          Market Revenue and Forecast (2016-2027)

8.1.3.     Oral Cavity

8.1.3.1.          Market Revenue and Forecast (2016-2027)

8.1.4.     Topical

8.1.4.1.          Market Revenue and Forecast (2016-2027)

8.1.5.     Other

8.1.5.1.          Market Revenue and Forecast (2016-2027)

Chapter 9.    Global Hydrogel-Based Drug Delivery System Market, Regional Estimates and Trend Forecast

9.1.  North America

9.1.1.     Market Revenue and Forecast, By Polymer Origin (2016-2027)

9.1.2.     Market Revenue and Forecast, By Delivery Route (2016-2027)

9.1.3.     U.S.

9.1.3.1.          Market Revenue and Forecast, By Polymer Origin (2016-2027)

9.1.3.2.          Market Revenue and Forecast, By Delivery Route (2016-2027)

9.1.4.     Rest of North America

9.1.4.1.          Market Revenue and Forecast, By Polymer Origin (2016-2027)

9.1.4.2.          Market Revenue and Forecast, By Delivery Route (2016-2027)

9.2.  Europe

9.2.1.     Market Revenue and Forecast, By Polymer Origin (2016-2027)

9.2.2.     Market Revenue and Forecast, By Delivery Route (2016-2027)

9.2.3.     UK

9.2.3.1.          Market Revenue and Forecast, By Polymer Origin (2016-2027)

9.2.3.2.          Market Revenue and Forecast, By Delivery Route (2016-2027)

9.2.4.     Germany

9.2.4.1.          Market Revenue and Forecast, By Polymer Origin (2016-2027)

9.2.4.2.          Market Revenue and Forecast, By Delivery Route (2016-2027)

9.2.5.     France

9.2.5.1.          Market Revenue and Forecast, By Polymer Origin (2016-2027)

9.2.5.2.          Market Revenue and Forecast, By Delivery Route (2016-2027)

9.2.6.     Rest of Europe

9.2.6.1.          Market Revenue and Forecast, By Polymer Origin (2016-2027)

9.2.6.2.          Market Revenue and Forecast, By Delivery Route (2016-2027)

9.3.  APAC

9.3.1.     Market Revenue and Forecast, By Polymer Origin (2016-2027)

9.3.2.     Market Revenue and Forecast, By Delivery Route (2016-2027)

9.3.3.     India

9.3.3.1.          Market Revenue and Forecast, By Polymer Origin (2016-2027)

9.3.3.2.          Market Revenue and Forecast, By Delivery Route (2016-2027)

9.3.4.     China

9.3.4.1.          Market Revenue and Forecast, By Polymer Origin (2016-2027)

9.3.4.2.          Market Revenue and Forecast, By Delivery Route (2016-2027)

9.3.5.     Japan

9.3.5.1.          Market Revenue and Forecast, By Polymer Origin (2016-2027)

9.3.5.2.          Market Revenue and Forecast, By Delivery Route (2016-2027)

9.3.6.     Rest of APAC

9.3.6.1.          Market Revenue and Forecast, By Polymer Origin (2016-2027)

9.3.6.2.          Market Revenue and Forecast, By Delivery Route (2016-2027)

9.4.  MEA

9.4.1.     Market Revenue and Forecast, By Polymer Origin (2016-2027)

9.4.2.     Market Revenue and Forecast, By Delivery Route (2016-2027)

9.4.3.     GCC

9.4.3.1.          Market Revenue and Forecast, By Polymer Origin (2016-2027)

9.4.3.2.          Market Revenue and Forecast, By Delivery Route (2016-2027)

9.4.4.     North Africa

9.4.4.1.          Market Revenue and Forecast, By Polymer Origin (2016-2027)

9.4.4.2.          Market Revenue and Forecast, By Delivery Route (2016-2027)

9.4.5.     South Africa

9.4.5.1.          Market Revenue and Forecast, By Polymer Origin (2016-2027)

9.4.5.2.          Market Revenue and Forecast, By Delivery Route (2016-2027)

9.4.6.     Rest of MEA

9.4.6.1.          Market Revenue and Forecast, By Polymer Origin (2016-2027)

9.4.6.2.          Market Revenue and Forecast, By Delivery Route (2016-2027)

9.5.  Latin America

9.5.1.     Market Revenue and Forecast, By Polymer Origin (2016-2027)

9.5.2.     Market Revenue and Forecast, By Delivery Route (2016-2027)

9.5.3.     Brazil

9.5.3.1.          Market Revenue and Forecast, By Polymer Origin (2016-2027)

9.5.3.2.          Market Revenue and Forecast, By Delivery Route (2016-2027)

9.5.4.     Rest of LATAM

9.5.4.1.          Market Revenue and Forecast, By Polymer Origin (2016-2027)

9.5.4.2.          Market Revenue and Forecast, By Delivery Route (2016-2027)

Chapter 10.   Company Profiles

10.1.                 GALDERMA

10.1.1.  Company Overview

10.1.2.  Product Offerings

10.1.3.  Financial Performance

10.1.4.  Recent Initiatives

10.2.                 Blairex Laboratories, Inc

10.2.1.  Company Overview

10.2.2.  Product Offerings

10.2.3.  Financial Performance

10.2.4.  Recent Initiatives

10.3.                 Johnson & Johnson

10.3.1.  Company Overview

10.3.2.  Product Offerings

10.3.3.  Financial Performance

10.3.4.  Recent Initiatives

10.4.                 Bausch and Lomb

10.4.1.  Company Overview

10.4.2.  Product Offerings

10.4.3.  Financial Performance

10.4.4.  Recent Initiatives

10.5.                 Medtronic

10.5.1.  Company Overview

10.5.2.  Product Offerings

10.5.3.  Financial Performance

10.5.4.  Recent Initiatives

10.6.                 Ocular Therapeutix, Inc

10.6.1.  Company Overview

10.6.2.  Product Offerings

10.6.3.  Financial Performance

10.6.4.  Recent Initiatives

10.7.                 Ferring B.V

10.7.1.  Company Overview

10.7.2.  Product Offerings

10.7.3.  Financial Performance

10.7.4.  Recent Initiatives

10.8.                 Endo International plc

10.8.1.  Company Overview

10.8.2.  Product Offerings

10.8.3.  Financial Performance

10.8.4.  Recent Initiatives

10.9.                 Akorn

10.9.1.  Company Overview

10.9.2.  Product Offerings

10.9.3.  Financial Performance

10.9.4.  Recent Initiatives

10.10.              Incorporated

10.10.1.                   Company Overview

10.10.2.                   Product Offerings

10.10.3.                   Financial Performance

10.10.4.                   Recent Initiatives

Chapter 11.   Research Methodology

11.1.                 Primary Research

11.2.                 Secondary Research

11.3.                 Assumptions

Chapter 12.   Appendix

12.1.                 About Us

12.2.                 Glossary of Terms